Table 3.  Potential for the two- and three-condition experimental design to detect relationships between placebo and experimental conditions, and true baseline values. Data are means (ฑ1 SD).

RMS Comparison

Time Period

vhip (cmทs-1)

ωankle (บทs-1)

WR2W-RMSmin

1-20

6.0 (1.8)

37.0 (12.0)

 

20-40

6.1 (3.0)

22.5 (7.7)

 

40-60

3.3 (1.4)

30.3 (12.6)

 

60-80

5.0 (1.7)

41.5 (24.4)

 

80-100

4.5 (1.4)

26.1 (21.5)

WR2R-RMSmin

1-20

5.0 (2.5)

21.2 (11.1)

 

20-40

5.6 (2.4)

31.3 (9.8)

 

40-60

6.0 (2.5)

27.5 (10.5)

 

60-80

7.6 (3.8)

28.3 (7.8)

 

80-100

4.9 (2.5)

19.6 (8.4)

WR2W-RMSmin

1-20

3.1 (1.9)

19.5 (11.3)

 

20-40

3.2 (1.7)

12.3 (9.4)

 

40-60

3.9 (2.2)

22.4 (12.3)

 

60-80

6.7 (4.9)

44.0 (20.6)

 

80-100

8.7 (4.2) *

30.5 (14.1)

WR2R-RMSmin

1-20

44.6 (11.1) †

76.1 (40.5) †

 

20-40

33.3 (7.6) †

153.9 (45.8) †

 

40-60

31.4 (8.6) †

148.2 (43.8) †

 

60-80

19.7 (7.7) †

123.8 (56.5) †

 

80-100

15.1 (12.3) †

45.0 (9.2) †
* Value is significantly greater than W-RMSavg (p < 0.05).
† Value is significantly greater than R-RMSavg (p < 0.05).